• Nicotine established a stable interaction with the conserved amino acids of sACE2 after COVID19 infection. • Nicotine could not establish proper contact with sACE2 protein in the healthy patients. • Nicotine reduced the overall binding affinity between sACE2 and RBD domain of SARS-CoV-2 protein. • Lower dosage of nicotine is required for reducing the binding affinity between sACE2-RBD protein complex.
7 November 2020 in Avicenna Journal of Medical Biotechnology
Background: Tau is a disordered Microtubule Associated Protein (MAP) which prefers to bind and stabilize microtubules. Phosphorylation of tau in particular enhances tau-tubulin interaction which otherwise detaches from tubulin during hyperphosphorylation. The reason behind their destabilization, detachment and the role of β subunit (from microtubule) and the projection domain (Tau) in microtubule stability remains elusive till date. Thus, a complete 3D structural investigation of tau protein is much needed to address these queries as the existing crystal structures are in fragments and quite limited. Methods: In this study, the modelled human tau protein was subjected to phosphorylation and hyperphosphorylation which were later considered for docking with microtubules (βα subunits-inter dimer) and vinblastine. Results: Phosphorylated tau protein interacts with both α- and β subunits. But stronger bonding was with α- compared to β subunits. Regarding β subunit, proline rich loop and projection domain actively participated in tau binding. Interestingly, hyperphosphorylation of tau increases MAP domain flexibility which ultimately results in tau detachment, the main reason behind tangle formation in Alzheimer’s disease. Conclusion: This study being the first of its kind emphasizes the role of projection domain and proline rich region of β-subunit in stabilizing the tau-tubulin interaction and also the effect of hyperphosphorylation in protein-protein and protein-drug binding.
12 February 2024 in Iranian Journal of Microbiology
Background and Objectives: Multiple outbreaks over two decades and a high mortality rate have emphasized the Nipah virus (NiV) as a priority research area. The study focuses on identifying the mutational landscape in sequences from NiV human isolates from different geographical regions. Materials and Methods: Thirty-seven NiV genomes of human samples from Malaysia, Bangladesh, and India were subject- ed to phylogeny and metagenomic analysis to decipher the genome variability using MEGA11 software and the meta-CATS web server. Using the Single-Likelihood Ancestor Counting method, the synonymous and nonsynonymous mutations among NiV genes were identified. Further, the nonsynonymous variations were used to identify mutations in all the NiV proteins. Results: The NiV isolates were categorized into NiV-M, NiV-B, and NiV-I clades based on phylogenetic analysis. Metag- enomic analysis revealed 1636 variations in the noncoding and coding regions of the genomes of the three clades of NiV. Further analysis of nonsynonymous mutations showed the phosphoprotein to be highly mutating, whereas the matrix protein was stable. Conclusion: Deciphering the mutation pattern using a comparative genomics approach for human isolates provided valuable insight into the stability of NiV proteins which can be further used for understanding variations in host-pathogen interaction and developing effective therapeutic measures.
1 July 2023 in Biomedical and Biotechnology Research Journal
Background: Since the emergence of the Nipah virus in Malaysia in 1998, two major variants of the virus, Nipah Virus Malaysian (NiV-M) and NiV Bangladesh (NiV-B) have been identified. The fatality rate of the NiV-B was reported to be above 75% which was significantly higher than that of the NiV-M at 40%. The NiV-B variant-infected patients presented additional clinical symptoms of respiratory distress along with the previously reported neurological symptoms and encephalitis. We carried out a comparative analysis of viral MicroRNA (miRNA) generated by NiV-M and NiV-B variants and found no common miRNAs between the strains. Methods: The genome sequence data for NiV-M and NiV-B were used to predict and validate the pre-miRNA using miRNAFold and miRNA-dis servers. The validated miRNAs were analyzed for secondary structural stability using RNAfold Web server and further mature miRNA were predicted using the Mature Bayes web server. The host targets for each of the predicted miRNAs were predicted using miRDB, followed by functional analysis of the target genes using Mediascape and DisGeNET. The functional annotations of crucial gene targets identified by Search Tool for the Retrieval of Interacting Genes/Proteins analysis were carried out using the Human protein atlas and PubMed. Results: The 43 mature miRNAs predicted for NiV-M targeted 1881 host genes and 47 miRNAs from the NiV-B genome had 1789 host gene targets while 458 host genes were shared between the two variants. Disease pathway engagement of the target genes derived by Disease Gene Network revealed as many as 142 target genes of the Bangladesh variant uniquely related to respiratory pathway distress while most target genes from NIV-M were related to neurological pathway disorders only. A comparison with other viral infection genes also showed a divergence in their mode of action. Literature surveys revealed that some of the target genes were previously known Food and Drug Administration-approved drug targets while others may serve as novel therapeutic targets. Conclusions: We believe that this study provides a plausible link between the molecular divergence of Nipah virus strains leading to differences in the clinical manifestation of the disease.